BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

839 related articles for article (PubMed ID: 28169581)

  • 21. NODDI, diffusion tensor microstructural abnormalities and atrophy of brain white matter and gray matter contribute to cognitive impairment in multiple sclerosis.
    Preziosa P; Pagani E; Meani A; Marchesi O; Conti L; Falini A; Rocca MA; Filippi M
    J Neurol; 2023 Feb; 270(2):810-823. PubMed ID: 36201016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis.
    Xiang B; Wen J; Cross AH; Yablonskiy DA
    J Magn Reson Imaging; 2019 Feb; 49(2):487-498. PubMed ID: 30155934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of Cortical and Deep Gray Matter Lesions in Multiple Sclerosis Using DIR and FLAIR at 3T.
    Park CC; Thongkham DW; Sadigh G; Saindane AM; Chu R; Bakshi R; Allen JW; Hu R
    J Neuroimaging; 2021 Mar; 31(2):408-414. PubMed ID: 33351983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Convergent effects of a functional C3 variant on brain atrophy, demyelination, and cognitive impairment in multiple sclerosis.
    Roostaei T; Sadaghiani S; Mashhadi R; Falahatian M; Mohamadi E; Javadian N; Nazeri A; Doosti R; Naser Moghadasi A; Owji M; Hashemi Taheri AP; Shakouri Rad A; Azimi A; Voineskos AN; Nazeri A; Sahraian MA
    Mult Scler; 2019 Apr; 25(4):532-540. PubMed ID: 29485352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of regional gray matter and white matter atrophy in cortical multiple sclerosis.
    Parisi L; Rocca MA; Mattioli F; Riccitelli GC; Capra R; Stampatori C; Bellomi F; Filippi M
    J Neurol; 2014 Sep; 261(9):1715-25. PubMed ID: 24952616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between Social Cognition and traditional cognitive impairment in Progressive Multiple Sclerosis and possible implicated neuroanatomical regions.
    Ciampi E; Uribe-San-Martin R; Vásquez M; Ruiz-Tagle A; Labbe T; Cruz JP; Lillo P; Slachevsky A; Reyes D; Reyes A; Cárcamo-Rodríguez C
    Mult Scler Relat Disord; 2018 Feb; 20():122-128. PubMed ID: 29414284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormalcortical thickness in relapsing-remitting multiple sclerosis, correlations with cognition impairment, and effect of modified Bushenyisui decoction on cognitive function of multiple sclerosis.
    Zhao X; Yang T; Cheng F; Yang S; Zhu W; Li S; Fan Y
    J Tradit Chin Med; 2021 Apr; 41(2):316-325. PubMed ID: 33825413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis.
    Riccitelli GC; Pagani E; Rodegher M; Colombo B; Preziosa P; Falini A; Comi G; Filippi M; Rocca MA
    Mult Scler; 2019 Feb; 25(2):204-216. PubMed ID: 29173009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gray matter networks and cognitive impairment in multiple sclerosis.
    Rimkus CM; Schoonheim MM; Steenwijk MD; Vrenken H; Eijlers AJ; Killestein J; Wattjes MP; Leite CC; Barkhof F; Tijms BM
    Mult Scler; 2019 Mar; 25(3):382-391. PubMed ID: 29320933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropsychological correlates of cerebellar volumes in multiple sclerosis: an MRI volumetric analysis study.
    Iliadou P; Bakirtzis C; Ioannidis P; Possin K; Zygouris S; Sintila SA; Grigoriadis N; Aretouli E
    J Integr Neurosci; 2022 Jan; 21(1):13. PubMed ID: 35164449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unraveling the substrates of cognitive impairment in multiple sclerosis: A multiparametric structural and functional magnetic resonance imaging study.
    Conti L; Preziosa P; Meani A; Pagani E; Valsasina P; Marchesi O; Vizzino C; Rocca MA; Filippi M
    Eur J Neurol; 2021 Nov; 28(11):3749-3759. PubMed ID: 34255918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subclinical MRI disease activity influences cognitive performance in MS patients.
    Damasceno A; Damasceno BP; Cendes F
    Mult Scler Relat Disord; 2015 Mar; 4(2):137-43. PubMed ID: 25787189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.
    Ramasamy DP; Benedict RH; Cox JL; Fritz D; Abdelrahman N; Hussein S; Minagar A; Dwyer MG; Zivadinov R
    J Neurol Sci; 2009 Jul; 282(1-2):47-54. PubMed ID: 19201003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glutamate-sensitive imaging and evaluation of cognitive impairment in multiple sclerosis.
    O'Grady KP; Dula AN; Lyttle BD; Thompson LM; Conrad BN; Box BA; McKeithan LJ; Pawate S; Bagnato F; Landman BA; Newhouse P; Smith SA
    Mult Scler; 2019 Oct; 25(12):1580-1592. PubMed ID: 30230400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
    Sacco R; Bisecco A; Corbo D; Della Corte M; d'Ambrosio A; Docimo R; Gallo A; Esposito F; Esposito S; Cirillo M; Lavorgna L; Tedeschi G; Bonavita S
    J Neurol; 2015 Jul; 262(7):1691-7. PubMed ID: 25957638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different cortical underpinnings for fatigue and depression in MS?
    Hanken K; Eling P; Klein J; Klaene E; Hildebrandt H
    Mult Scler Relat Disord; 2016 Mar; 6():81-86. PubMed ID: 27063629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study.
    Hidalgo de la Cruz M; Valsasina P; Meani A; Gallo A; Gobbi C; Bisecco A; Tedeschi G; Zecca C; Rocca MA; Filippi M
    Mult Scler; 2022 Mar; 28(3):406-417. PubMed ID: 34124963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal cortical thinning progression differs across multiple sclerosis phenotypes and is clinically relevant: A multicentre study.
    Hidalgo de la Cruz M; Valsasina P; Gobbi C; Gallo A; Zecca C; Bisecco A; Tedeschi G; Filippi M; Rocca MA
    Mult Scler; 2021 May; 27(6):827-840. PubMed ID: 32662748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment.
    Megna R; Alfano B; Lanzillo R; Costabile T; Comerci M; Vacca G; Carotenuto A; Moccia M; Servillo G; Prinster A; Brescia Morra V; Quarantelli M
    J Neurol; 2019 Feb; 266(2):361-368. PubMed ID: 30498912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcortical gray matter atrophy is associated with cognitive deficit in multiple sclerosis but not in systemic lupus erythematosus patients.
    Kalinowska-Łyszczarz A; Pawlak MA; Pietrzak A; Pawlak-Buś K; Leszczyński P; Puszczewicz M; Majewski D; Paprzycki W; Kozubski W; Michalak S
    Lupus; 2018 Apr; 27(4):610-620. PubMed ID: 28992796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.